Phase-I Study of the new B-Cell Lymphoma 2 (BCL2) Inhibitor BGB-11417 as Monotherapy or in Combination with Zanubrutinib (zanu) in Patients (pat) with B-Cell Malignancies: preliminary Data

被引：0
|
作者：
Stilgenbauer, S. [1 ]
Opat, S. [2 ,3 ]
Cheah, C. Y. [4 ,5 ,6 ,7 ]
Lasica, M. [8 ]
Verner, E. [9 ,10 ]
Browett, P. J. [11 ]
Chan, H. [12 ]
Soumerai, J. D. [13 ]
Gonzalez, Barca E. [14 ]
Hilger, J. [15 ]
Fang, Y. [16 ]
Simpson, D. [15 ]
Tam, C. S. [17 ,18 ,19 ]
机构：
[1] Univ Ulm, Ulm, Germany
[2] Monash Hlth, Clayton, Australia
[3] Monash Univ, Clayton, Australia
[4] Sir Charles Gairdner Hosp, Nedlands, Australia
[5] Pathwest Lab Med, Nedlands, Australia
[6] Univ Western Australia, Sch Med, Crawley, Australia
[7] Linear Clin Res, Nedlands, Australia
[8] St Vincents Hosp Melbourne, Fitzroy, Australia
[9] Concord Repatriat Gen Hosp, Concord, Australia
[10] Univ Sydney, Sydney, Australia
[11] Auckland City Hosp, Auckland, New Zealand
[12] North Shore Hosp, Auckland, New Zealand
[13] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[14] Univ Barcelona, Inst Catala Oncol Hosp, Barcelona, Spain
[15] BeiGene USA Inc, San Mateo, CA USA
[16] BeiGene Beijing Co Ltd, Beijing, Peoples R China
[17] Peter MacCallum Canc Ctr, Melbourne, Australia
[18] Univ Melbourne, Parkville, Australia
[19] Royal Melbourne Hosp, Parkville, Australia
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V91
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [11] BGB-11417-203, an Ongoing, Phase 2 Study of Sonrotoclax (BGB-11417), a Next-Generation BCL2 Inhibitor, in Patients With Waldenström Macroglobulinemia
    Lee, Hui-Peng
    Opat, Stephen S.
    Hrom, John
    Kliman, David
    Marlton, Paula
    Liu, Peng
    Du, Chenmu
    Lussier, Amber
    Zhang, Jun
    Guo, Haiyi
    Treon, Steven P.
    BLOOD, 2024, 144 : 16611 - 16612
  • [12] BGB-11417-203: An ongoing, phase 2 study of sonrotoclax (BGB-11417), a next-generation BCL2 inhibitor, in patients with Waldenstrom macroglobulinemia.
    Lee, Hui-Peng
    Opat, Stephen
    Hrom, John
    Kliman, David S.
    Marlton, Paula
    Liu, Peng
    Du, Chenmu
    Lussier, Amber
    Zhang, Jun
    Guo, Haiyi
    Treon, Steven P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [13] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
    Baik, Jeeyeon
    Isgor, Irem
    Aypar, Umut
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
  • [14] BCL2 overexpression in diffuse large B-cell lymphoma
    Monni, O
    Franssila, K
    Joensuu, H
    Knuutila, S
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 45 - 52
  • [15] BCL2 mutations in diffuse large B-cell lymphoma
    Schuetz, J. M.
    Johnson, N. A.
    Morin, R. D.
    Scott, D. W.
    Tan, K.
    Ben-Nierah, S.
    Boyle, M.
    Slack, G. W.
    Marra, M. A.
    Connors, J. M.
    Brooks-Wilson, A. R.
    Gascoyne, R. D.
    LEUKEMIA, 2012, 26 (06) : 1383 - 1390
  • [16] BCL2 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Schuetz, J.
    Johnson, N.
    Morin, R.
    Marra, M.
    Connors, J.
    Brooks-Wilson, A.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2011, 22 : 207 - 207
  • [17] BCL2 mutations in diffuse large B-cell lymphoma
    J M Schuetz
    N A Johnson
    R D Morin
    D W Scott
    K Tan
    S Ben-Nierah
    M Boyle
    G W Slack
    M A Marra
    J M Connors
    A R Brooks-Wilson
    R D Gascoyne
    Leukemia, 2012, 26 : 1383 - 1390
  • [18] PHASE-I IMMUNOTOXIN TRIAL IN PATIENTS WITH B-CELL LYMPHOMA
    VITETTA, ES
    STONE, M
    AMLOT, P
    FAY, J
    MAY, R
    TILL, M
    NEWMAN, J
    CLARK, P
    COLLINS, R
    CUNNINGHAM, D
    GHETIE, V
    UHR, JW
    THORPE, PE
    CANCER RESEARCH, 1991, 51 (15) : 4052 - 4058
  • [19] Phase 2 Study of Zanubrutinib in BTK Inhibitor-Intolerant Patients (Pts) with Relapsed/Refractory B-Cell Malignancies
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe Y.
    Porter, Ryan
    Burke, John M.
    Cultrera, Jennifer L.
    Misleh, Jamal
    Zafar, Syed F.
    Freeman, Benjamin
    Rao, Subramanya S.
    Yimer, Habte
    Chaudhry, Arvind
    Gandhi, Mitul D.
    Guthrie, Troy H.
    Kingsley, Edwin
    Tumula, Praveen K.
    Manda, Sudhir
    Chen, Dih-Yih
    Cohen, Aileen
    By, Kunthel
    Xu, Linlin
    Liu, Ye
    Sharman, Jeff P.
    BLOOD, 2021, 138
  • [20] Prognostic significance evaluation of B-cell lymphoma 2 (BCL2) and Ki-67 expression in diffuse large B-cell lymphoma patients
    Rahimi, Hossein
    Borojerdi, Zahra Rezaei
    Azimi, Sajad Ataei
    Rashidian, Elnaz
    Jafarian, Amirhossein
    IMMUNOPATHOLOGIA PERSA, 2020, 6 (01):
12345